Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
Neuroscience & Brain Research

Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer

Rifan Muazin Apr 5, 2026 0

In a landmark study that bridges the traditionally separate fields of neurology and oncology, researchers at the Houston Methodist Research…

Read More
Neuroscience & Brain Research

Houston Methodist Researchers Identify TDP43 Protein as a Key Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer

Rifan Muazin Mar 19, 2026 0

In a landmark study that bridges two historically distinct fields of medicine, researchers at the Houston Methodist Research Institute have…

Read More
Psilocybin Induces Lasting Brain Connectivity Changes and Psychological Insight According to New UCSF and Imperial College London StudyCanada Invests C$79 Million in Aspect Biosystems to Accelerate Development of Bioengineered Cellular Medicines for Endocrine and Metabolic DiseasesTWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Resurging Public Health ThreatsUnveiling the Microscopic Thermometer: Scientists Capture First Detailed Images of the Body’s Cold Sensor at Work
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ